毒物学的薬物スクリーニング市場：製品、検査、用途別-2025-2030年の世界予測

毒物学的薬物スクリーニング市場は、2023年に270億7,000万米ドルと評価され、2024年には305億9,000万米ドルに達すると予測され、CAGR 13.38％で成長し、2030年には652億2,000万米ドルに達すると予測されています。

毒物学的薬物スクリーニング市場は、生体サンプル中の薬物およびその代謝物の存在と濃度の検出に焦点を当てた医療診断分野と定義されます。同市場は、薬物乱用の増加、職場、スポーツ、法的環境における日常的な薬物検査の必要性、新薬に対する需要の高まりにより、極めて重要な位置を占めています。用途はヘルスケア、スポーツ、刑事司法、職場の安全性など多岐にわたり、最終用途は病院、研究所、法執行機関、家庭内検査などです。主な成長促進要因としては、薬物乱用の増加、薬物スクリーニングを義務付ける厳しい規制、検査キットの技術進歩、職場の薬物検査重視の高まりなどが挙げられます。新たな市場開拓のチャンスは、認知度と普及がまだ浅い新興国市場への進出と、迅速で非侵襲的な検査方法の開発にあります。さらに、毒物検査におけるデータ分析にAIと機械学習を活用することは、大きな可能性を秘めています。

逆に、市場は検査機器の高コスト、検査精度に影響する偽陽性、プライバシーの問題、規制の複雑さなどの制約に直面しています。さらに、地域によっては薬物検査にまつわる汚名が市場成長の妨げになることもあります。技術革新は、より手頃な価格で正確な検査キット、小型化されたポイント・オブ・ケア機器の開発、検査プロセスのスピード改善に焦点を当てることができます。特に、唾液や呼気分析のような非侵襲的検査法の研究は有望な手段となります。市場競争は激しく、既存企業は技術的進歩や戦略的提携に注力する一方、新規参入企業は個別化医療や特定の薬物カテゴリーといったニッチ分野を開拓する可能性があります。利便性の高さから遠隔検査や在宅検査への継続的な動向は、この進化する市場の性質をさらに際立たせています。したがって、成長を目指す企業は、研究開発、戦略的パートナーシップ、地域のニーズに合わせた市場拡大戦略に投資すべきです。

市場力学：急速に進化する毒物学的薬物スクリーニング市場の主要市場インサイトを公開

毒物学的薬物スクリーニング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 職場での薬物検査の増加とPOCT（ポイント・オブ・ケア・テスト）機器の高い普及率
  • ハイエンドの薬物スクリーニング機器、試薬、キットの入手可能性の増加
  • 毒性検査に対する政府支出の増加
• 市場抑制要因
  • 毒物学的薬物スクリーニング検査の高コスト
• 市場機会
  • 高度な毒物学的薬物スクリーニング検査のイントロダクション
  • 飲食品業界、化学業界における毒物学的薬物スクリーニング採用の増加
• 市場の課題
  • 毒物学的薬物スクリーニングに伴うサンプル検査時間の長期化

ポーターの5つの力：毒物学的薬物スクリーニング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、毒物学的薬物スクリーニング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：毒物学的薬物スクリーニング市場における外部からの影響の把握

外部マクロ環境要因は、毒物学的薬物スクリーニング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析毒物学的薬物スクリーニング市場における競合情勢の把握

毒物学的薬物スクリーニング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス毒物学的薬物スクリーニング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、毒物学的薬物スクリーニング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨毒物学的薬物スクリーニング市場における成功への道筋を描く

毒物学的薬物スクリーニング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 職場での薬物検査の実施の増加とポイントオブケア検査（POCT）機器の普及率の高さ
    • 高性能な薬物スクリーニング機器、試薬、キットの入手可能性の向上
    • 毒性試験に対する政府支出の増加
  • 抑制要因
    • 毒物学的薬物スクリーニングテストの高コスト
  • 機会
    • 高度な毒物学的薬物スクリーニングテストのイントロダクション
    • 食品・飲料業界、化学業界での毒物学的薬物スクリーニングの採用増加
  • 課題
    • 毒物学的薬物スクリーニングに関連するサンプルテストの所要時間が長くなります
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 毒物学的薬物スクリーニング市場：製品別

• 動物モデル
• 機器
• 試薬・消耗品
• ソフトウェア

第7章 毒物学的薬物スクリーニング市場テスト別

• シミュレーション
• In vitro（体外）
• In vivo

第8章 毒物学的薬物スクリーニング市場：用途別

• 発達および生殖毒性
• 内分泌かく乱
• 免疫毒性
• 全身毒性

第9章 南北アメリカの毒物学的薬物スクリーニング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の毒物学的薬物スクリーニング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの毒物学的薬物スクリーニング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Bio-Rad Laboratories Inc.
• Charles River Laboratories International, Inc.
• Clinical Reference Laboratory, Inc.
• Enzo Life Sciences, Inc.
• Eurofins Scientific SE
• GE Healthcare
• Laboratory Corporation of America Holdings
• Promega Corporation
• Quest Diagnostics
• Selvita S.A.
• Thermo Fisher Scientific Inc.
• Waters Corporation
• Wuxi AppTec Co., Ltd.

LIST OF FIGURES

• FIGURE 1. TOXICOLOGY DRUG SCREENING MARKET RESEARCH PROCESS
• FIGURE 2. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TOXICOLOGY DRUG SCREENING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TOXICOLOGY DRUG SCREENING MARKET DYNAMICS
• TABLE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ANIMAL MODELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DEVELOPMENTAL & REPRODUCTIVE TOXICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SYSTEMICTOXICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 33. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 50. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 53. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 105. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 117. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 120. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

The Toxicology Drug Screening Market was valued at USD 27.07 billion in 2023, expected to reach USD 30.59 billion in 2024, and is projected to grow at a CAGR of 13.38%, to USD 65.22 billion by 2030.

The toxicology drug screening market is defined as the segment of medical diagnostics focused on detecting the presence and concentration of drugs and their metabolites in biological samples. This market is crucial due to rising substance abuse, the need for routine drug testing in workplaces, sports, legal environments, and the growing demand for new drugs. The applications extend to healthcare, sports, criminal justice, and workplace safety, while the end-use scope largely includes hospitals, laboratories, law enforcement agencies, and in-home testing. Key growth drivers include the increasing prevalence of drug abuse, stringent regulations mandating drug screening, technological advancements in testing kits, and a growing emphasis on workplace drug testing. Emerging opportunities lie in expanding into emerging markets where awareness and adoption are still nascent and developing rapid, non-invasive testing methods. Additionally, leveraging AI and machine learning for data analysis in toxicology screens offers significant potential.

Conversely, the market faces limitations such as the high cost of testing equipment, false positives affecting test accuracy, privacy concerns, and regulatory complexities. Moreover, the stigma associated with drug testing in certain regions can hinder market growth. Innovations could focus on developing more affordable and accurate testing kits, miniaturized point-of-care devices, and improving the speed of testing processes. Particularly, research into non-invasive testing methods like saliva or breath analysis offers promising avenues. The market is competitive, with established players focusing on technological advancements and strategic partnerships, while new entrants might explore niche areas such as personalized medicine or specific drug categories. The continued trend toward remote and home testing due to its convenience further underlines the nature of this evolving market. Therefore, companies aiming for growth should invest in research and development, strategic partnerships, and market expansion strategies tailored to localized needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Toxicology Drug Screening Market

The Toxicology Drug Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
  • Growing availability of high-end drug screening instruments, reagent and kits
  • Rising government expenditure on toxicity testing
• Market Restraints
  • High Cost of toxicology drug screening tests
• Market Opportunities
  • Introduction of advanced toxicology drug screening tests
  • Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
• Market Challenges
  • Longer time for sample testing associated with toxicology drug screening

Porter's Five Forces: A Strategic Tool for Navigating the Toxicology Drug Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Toxicology Drug Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Toxicology Drug Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Toxicology Drug Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Toxicology Drug Screening Market

A detailed market share analysis in the Toxicology Drug Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Toxicology Drug Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Toxicology Drug Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Toxicology Drug Screening Market

A strategic analysis of the Toxicology Drug Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Toxicology Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International, Inc., Clinical Reference Laboratory, Inc., Enzo Life Sciences, Inc., Eurofins Scientific SE, GE Healthcare, Laboratory Corporation of America Holdings, Promega Corporation, Quest Diagnostics, Selvita S.A., Thermo Fisher Scientific Inc., Waters Corporation, and Wuxi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Toxicology Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Animal Models, Instruments, Reagents & Consumables, and Software.
• Based on Testing, market is studied across In Silico, In Vitro, and In Vivo.
• Based on Application, market is studied across Developmental & Reproductive Toxicity, Endocrine Disruption, Immunotoxicity, and Systemictoxicity.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
    • 5.1.1.2. Growing availability of high-end drug screening instruments, reagent and kits
    • 5.1.1.3. Rising government expenditure on toxicity testing
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of toxicology drug screening tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of advanced toxicology drug screening tests
    • 5.1.3.2. Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
  • 5.1.4. Challenges
    • 5.1.4.1. Longer time for sample testing associated with toxicology drug screening
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Toxicology Drug Screening Market, by Product

• 6.1. Introduction
• 6.2. Animal Models
• 6.3. Instruments
• 6.4. Reagents & Consumables
• 6.5. Software

7. Toxicology Drug Screening Market, by Testing

• 7.1. Introduction
• 7.2. In Silico
• 7.3. In Vitro
• 7.4. In Vivo

8. Toxicology Drug Screening Market, by Application

• 8.1. Introduction
• 8.2. Developmental & Reproductive Toxicity
• 8.3. Endocrine Disruption
• 8.4. Immunotoxicity
• 8.5. Systemictoxicity

9. Americas Toxicology Drug Screening Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Toxicology Drug Screening Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Toxicology Drug Screening Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Bio-Rad Laboratories Inc.
• 4. Charles River Laboratories International, Inc.
• 5. Clinical Reference Laboratory, Inc.
• 6. Enzo Life Sciences, Inc.
• 7. Eurofins Scientific SE
• 8. GE Healthcare
• 9. Laboratory Corporation of America Holdings
• 10. Promega Corporation
• 11. Quest Diagnostics
• 12. Selvita S.A.
• 13. Thermo Fisher Scientific Inc.
• 14. Waters Corporation
• 15. Wuxi AppTec Co., Ltd.